SEARCH

SEARCH BY CITATION

References

  • 1
    Chen MF, Wu CT, Chen YJ, Keng PC & Chen WC (2004) Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. J Radiat Res 45, 253260.
  • 2
    Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC & Tseng TH (2003) Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol 15, 22812289.
  • 3
    Chiao C, Carothers AM, Grunberger D, Solomon G, Preston GA & Barrett JC (1995) Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cell. Cancer Res 16, 35763583.
  • 4
    Song JJ, Lim HW, Kim K, Kim KM, Cho S & Chae SW (2012) Effect of caffeic acid phenethyl ester (CAPE) on H2O2 induced oxidative and inflammatory responses in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol 76, 675679.
  • 5
    Korish AA & Arafa MM (2011) Propolis derivatives inhibit the systemic inflammatory response and protect hepatic and neuronal cells in acute septic shock. Braz J Infect Dis 15, 332338.
  • 6
    Boudreau LH, Maillet J, LeBlanc LM, Jean-François J, Touaibia M, Flamand N & Surette ME (2011) Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes. PLoS One 7, e31833.
  • 7
    Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J & Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48, 595608.
  • 8
    Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV & Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329, 2124.
  • 9
    Jin UH, Song KH, Motomura M, Suzuki I, Gu YH, Kang YJ, Moon TC & Kim CH (2008) Caffeic acid phenethyl ester induces mitochondria-mediated apoptosis in human myeloid leukemia U937 cells. Mol Cell Biochem 310, 4348.
  • 10
    Eşrefoğlu M, Gül M, Ateş B & Erdoğan A (2011) The effects of caffeic acid phenethyl ester and melatonin on age-related vascular remodeling and cardiac damage. Fundam Clin Pharmacol 25, 580590.
  • 11
    Su ZZ, Lin J, Grunberger D & Fisher PB (1994) Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression. Cancer Res 54, 18651870.
  • 12
    Kudugunti SK, Vad NM, Whiteside AJ, Naik BU, Yusuf MA, Srivenugopal KS & Moridani MY (2010) Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. Chem Biol Interact 188, 114.
  • 13
    Bhimani RS, Troll W, Grunberger D & Frenkel K (1993) Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res 53, 45284533.
  • 14
    Watabe M, Hishikawa K, Takayanagi A, Shimizu N & Nakaki T (2004) Caffeic acid phenethyl ester induces apoptosis by inhibition of NF-κB and activation of Fas in human breast cancer MCF-7 cells. J Biol Chem 279, 60176026.
  • 15
    DeGregori J & Johnson DG (2006) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6, 739748.
  • 16
    Holmberg C, Helin K, Sehested M & Karlstrom O (1998) E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene 17, 143155.
  • 17
    Hershko T, Chaussepied M, Oren M & Ginsberg D (2005) Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 12, 377383.
  • 18
    Tamrakar S, Rubin E & Ludlow JW (2000) Role of pRB dephosphorylation in cell cycle regulation. Front Biosci 1, D121D137.
  • 19
    Ivanova IA, D'Souza SJ & Dagnino L (2005) Signalling in the epidermis: the E2F cell cycle regulatory pathway in epidermal morphogenesis, regeneration and transformation. Int J Biol Sci 1, 8795.
  • 20
    Innocente SA, Abrahamson JL, Cogswell JP & Lee JM (1999) p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96, 21472152.
  • 21
    Zhu WC, Giangrande PH & Nevins JR (2004) E2Fs link the control of G1/S and G2/M transcription. EMBO J 23, 46154626.
  • 22
    Chen MJ, Chang WH, Lin CC, Liu CY, Wang TE, Chu CH, Shih SC & Chen YJ (2008) Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction. Pancreatology 8, 566576.
  • 23
    Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16, 117.
  • 24
    Moroni MC, Hickman ES, Denchi EL, Caprara G, Coli E, Cecconi F, Muller H & Helin K (2001) Apaf-1 is a transcriptional target for E2F1 and p53. Nat Cell Biol 3, 552558.
  • 25
    Croxton R, Ma Y, Song L, Haura E & Cress WD (2002) Direct repression of the Mcl-1 promoter by E2F1. Oncogene 21, 13591369.
  • 26
    Hsu LY, Lin CF, Hsu WC, Hsu WL & Chang TC (2005) Evaluation of polyphenolic acid esters as potential antioxidants. Biol Pharm Bull 28, 12111215.
  • 27
    Pecoraro G, Morgan D & Defendi V (1989) Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci USA 86, 563567.
  • 28
    Chou CY, Shen MR & Wu SN (1995) Volume-sensitive chloride channels associated with human cervical carcinogenesis. Cancer Res 55, 60776083.
  • 29
    Ding DC, Chiang MH, Lai HC, Hsiung CA, Hsieh CY & Chu TY (2009) Methylation of the long control region of Hpv16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol 147, 215220.
  • 30
    Mundle SD & Saberwal G (2003) Evolving intricacies and implications of E2F1 regulation. FASEB J 17, 569574.
  • 31
    Hallstrom TC & Nevins JR (2003) Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc Natl Acad Sci USA 100, 1084510848.
  • 32
    Pützer BM (2007) E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 11, 239251.
  • 33
    Stanelle J & Pützer BM (2006) E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol Med 12, 177185.
  • 34
    Meng RD, Phillips P & El-Deiry WS (1999) p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol 14, 514.
  • 35
    Dong YB, Yang HL, Elliott MJ & McMasters KM (2002) Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Cancer Res 62, 17761783.
  • 36
    Chang TC, Tsai LC, Hung MW, Chu LL, Chu JT & Chen YT (1997) Effects of transcriptional and translational inhibitors on a human gastric cancer cell line: potential role of Bcl-Xs in apoptosis triggered by these inhibitors. Biochem Pharmacol 53, 969977.
  • 37
    Kirch HC, Pützer B, Schwabe G, Gnauck HK & Schulte HH (1993) Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation. Cell Mol Biol Res 39, 705716.